Altimmune Inc (ALT)

$12.01 0.47 (3.77%)

16:00 EDT ALT Stock Quote Delayed 30 Minutes

ALT Stock: One Analyst Still Thinks Altimmune Prices Could Hit $34

By Samuel O'Brient, InvestorPlace Financial News Writer Sep 28, 2021

Some clinical trial results released by Altimmune have shareholders rushing to sell. But, one analyst sees plenty of upside for ALT stock.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

2020 In Review — 9 Great (And Not-So-Great) Calls

More Articles

Volume:

Previous Close -

Market Cap 476.87M

PE Ratio -7.11

EPS -1.69

Volume (Avg. Vol.) 671,624

Day's Range 11.98 - 12.52

52-Week Range 7.80 - 24.61

Dividend & Yield N/A (N/A)

ALT Stock Predictions, Articles, and Altimmune Inc News

From InvestorPlace
From the Web

Altimmune Earnings: ALT Stock Rises 7% Despite Rough Q2 Results

By Nick Clarkson, Web Editor Aug 12, 2020

Altimmune earnings from Tuesday evening have ALT stock higher despite the company reporting rough figures for second quarter of FY2020.

Altimmune Earnings: ALT Stock Tumbles 12% on FY Miss

By William White, InvestorPlace Writer Mar 27, 2020

Altimmune (ALT) earnings for the biopharmaceutical company's fiscal year of 2019 have ALT stock taking a dive Friday after missing estimates.

Altimmune Stock Has Major Pipeline Potential

By Louis Navellier and the InvestorPlace Research Staff Mar 18, 2020

There's no guarantee of a coronavirus cure, but Altimmune stock is worth owning on hopes of an effective vaccine.

Altimmune News: ALT Stock Rockets 110% on Coronavirus Vaccine News

By William White, InvestorPlace Writer Feb 28, 2020

Altimmune (ALT) news for Monday includes positive news about a vaccine to treat the coronavirus from China have ALT stock soaring higher.

Altimmune News: ALT Stock Skyrockets on Positive Flu Vaccine Data

By William White, InvestorPlace Writer Mar 19, 2019

Altimmune news concerning the results from a Phase 2 extension study of the company's NasoVAX has ALT stock heading higher today.

Why Altimmune Stock Is Sliding Lower Today

By William White, InvestorPlace Writer Oct 8, 2018

Altimmune stock was falling hard Monday on news that the company is selling additional stock to investors in a new offering.

Why Altimmune Stock Is Skyrocketing Today

By Karl Utermohlen, InvestorPlace Writer Sep 19, 2018

Altimmune stock (ALT) soared more than 285% following successful clinical trial data of a medication and a reverse split of common shares.

The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug

From Benzinga Sep 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc. (...

52 Biggest Movers From Yesterday

From Benzinga Sep 30, 2021

Gainers Paltalk, Inc. (NASDAQ: PALT) shares jumped 60.1% to close at $8.39 on Wednesday. Smart Share Global Limited (NASDAQ: EM) jumped 36.2% to close at $3.91. Smart Share...

H.C. Wainwright Sees Buying Opportunity In This Biotech Stock Sell Off

From Benzinga Sep 28, 2021

H.C. Wainwright said that Altimmune Inc (NASDAQ:

12 Health Care Stocks Moving In Wednesday's Intraday Session

From Benzinga Sep 29, 2021

Gainers NuCana (NASDAQ:NCNA) stock increased by 22.36% to $2.9 during Wednesday's regular session. The current volume of 77.9 million shares is 21650.59% of NuCana...

33 Stocks Moving In Wednesday's Mid-Day Session

From Benzinga Sep 29, 2021

Gainers Paltalk, Inc. (NASDAQ: PALT) shares climbed 37% to $7.18. NuCana plc (NASDAQ: NCNA) jumped 31.4% to $3.1150. The FDA granted Fast Track designation to NuCana’s...

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

From Benzinga Sep 29, 2021

Gainers Geovax Labs (NASDAQ:GOVX) shares increased by 23.44% to $5.16 during Wednesday's pre-market session. The market value of their outstanding shares is at $32.6...